Oncology CME Courses

Oncology CME Courses

Credits: 1.0 (AMA PRA Category 1)
Format: Online Streaming Video
Price: Free
Release Date: May 12, 2016
Expiration Date: May 12, 2018
Summary:

Acute lymphoblastic leukemia (ALL) is one of a group of malignancies caused by cytogenetic DNA mutations of developing hematopoietic stem cell precursors and mostly common to children with peak incidence at 2-5 years of age. Although approximately 80% of ALL cases present in children, they also occur in adults.  The symptoms of ALL are non-specific and similar to those of acute myelogenous leukemia (AML), which patients usually have 1-3 months of complaints.

By the end of the session the participant will be able to:

  • Summarize the most impactful findings presented at ASH 2015 relating to ALL and apply them to patient cases, taking into account any relevant barriers to care.
  • Additional objectives to be dictated by clinical content
Credits: 2 (AMA PRA Category 1)
Format: Online Streaming Video
Price: Free
Release Date: 9/29/2017
Expiration Date: 9/29/2018
Summary:

This activity is intended for pediatric oncology nurses, pediatric nurses, oncology nurses, nurse practitioners, nurse managers, infusion nurses, research nurses, physician assistants, and other health care providers who care for or have an interest in pediatric patients with high-risk neuroblastoma

Credits: 1 (AMA PRA Category 1)
Format: Online Streaming Video, PDF, Online Download, Interactive Online
Price: Free
Release Date: October 19, 2017
Expiration Date: October 19, 2019
Summary:

Colorectal cancer (CRC) is the third-leading cause of cancer deaths in the U.S. While a majority of patients are diagnosed before their disease has metastasized, a fifth of patients have advanced disease at the time of diagnosis. Early detection and screening have been shown to significantly reduce CRC mortality, and screening is widely recommended for average-risk adults beginning at age 50 years, (as well as earlier for individuals at higher risk). Since the mid-1990s, the U.S. Preventive Services Task Force, American Cancer Society, and other groups have recommended several modalities for screening: fecal occult blood testing (FOBT), flexible sigmoidoscopy, colonoscopy, and barium enema. Recent years have seen the addition of newer screening technologies, including stool DNA, computed tomographic colonography, and capsule endoscopy.

By the end of the session the participant will be able to:

  • Describe present the current practice guideline recommendations with respect to colorectal cancer screening, including colonoscopy preparation, and apply them to patient cases
  • Identify the treatment modalities currently available for management of mCRC and apply them to patient cases using evidence-based medicine
  • Evaluate a treatment plan for a specific patient with mCRC to optimize safety, efficacy, and tolerability, suggesting modifications for improvement
  • Describe the challenges and barriers to care associated with treating patients with mCRC
Credits: 1 (AMA PRA Category 1)
Format: Interactive Online, Online Streaming Video, PDF
Price: Free
Release Date: November 02, 2017
Expiration Date: November 02, 2019
Summary:

Multiple myeloma (MM) is a hematologic malignancy of the lymphocytes. All cases are marked by monoclonal gammopathy, and while the true cause is unknown, associated factors are thought to include: radiation, genetics, viral infections, and the human immunodeficiency virus. Helping the clinician discern the role of each of the first-line and more novel therapies, including monoclonal antibodies and proteasome, deacetylase, and 3 serine/threonine protein kinase inhibitor therapies – among others – based on the most up-to-date research merits continuing education programming in MM.

By the end of the session the participant will be able to:

  • Recall updates in the staging, prognosis, and diagnosis of MM.
  • Distinguish between the most appropriate treatment approaches to MM and apply them to practice, taking into account the following: treatment modalities and the recent clinical trial evidence supporting them.
  • Distinguish between the most appropriate treatment approaches to MM and apply them to practice, taking into account the following: evidence-based treatment guidelines, algorithms, and expert opinion.
  • Summarize the risk-benefit profiles of current and emerging therapies for the treatment of MM.
Credits: 13.5 (AMA PRA Category 1)
Format: Online Streaming Video
Price: $795
Release Date: December 31, 2018
Expiration Date: December 31, 2021
Summary:

This CME program, featuring experts in the practice of Breast Pathology, is a comprehensive review of the core concepts and emerging trends in the field. Masters of Pathology Series  Breast Pathology covers updates on ER/PR/HER2 testing, contemporary issues in core needle biopsy, deceptive patterns and mimics of invasive breast cancer, and more. It will help you to better:

  • Evaluate diagnostic criteria and clinical significance of common and uncommon benign, in situ, and malignant lesions
  • Address differential diagnostic problems commonly encountered in breast pathology
  • Gain the latest information on the uses and limitations of IHC in diagnostic breast pathology
  • Understand the latest guidelines for ER, PR and HER2 testing and reporting



Credits: 26.25 (AMA PRA Category 1)
Format: Online Streaming Video, MP3, MP4, Multiple Formats
Price: $1,595
Release Date: November 15, 2018
Expiration Date: November 15, 2021
Summary:

Two Great Products. One Extraordinary CME Value.

If you have been thinking about making a commitment to your continuing medical education, this is the time to do it!

Here’s what you get:

  • From CMEinfo  Radiation Oncology - A Comprehensive Review led by Christopher G. Willett, MD, and featuring lectures for an all-encompassing clinical update
  • From Practical Reviews — A one-year subscription, including our FREE mobile app
  • A $500 Amazon.com® gift card
  • Unbiased content to help you prep for the boards and stay current without the need for travel or time away from your practice
  • Instant online access to key clinical updates to improve overall patient care
  • The opportunity to earn up to 85 AMA PRA Category 1 Credits  combined
Credits: 1 (AMA PRA Category 1)
Format: Interactive Online
Price: Free
Expiration Date: 6/14/18
Summary:

Speakers:

Matthew H. Kulke, MD, MMSc, Associate Professor of Medicine, Director of the Neuroendocrine and Carcinoid Tumor Program at Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School

David C. Metz, MBBCh, is Professor of Medicine at the Perelman School of Medicine (University of Pennsylvania)

Topic and Learning Objectives

  • To incorporate evidence-based practices into the management of carcinoid syndrome
  • Review the efficacy and safety of treatment programs for carcinoid syndrome
  • To summarize the causes of carcinoid syndrome
  • Review the differential diagnosis and appropriate workup for the presenting symptoms

This activity is intended for US-based medical oncologists, endocrinologists and gastroenterologists, as well as oncology physician assistants, nurse practitioners, and nurses involved in the diagnosis and management of carcinoid tumors and carcinoid syndrome. Considering the symptoms and potential complications involved in carcinoid syndrome, clinicians in cardiology, dermatology, pulmonary medicine, surgery, radiology (including interventional, diagnostic, and nuclear medicine), internal medicine and primary care may also benefit from education.

Credits: 29 (AMA PRA Category 1)
Format: Online Streaming Video
Price: $995
Release Date: November 15, 2018
Expiration Date: November 15, 2021
Summary:

Explore Key Topics

Featuring experts in the practice of Radiation Oncology, this CME program focuses on core concepts and emerging trends. Radiation Oncology – A Comprehensive Review includes case-based lectures on topics like proton radiation therapy in adults, radiation therapy for prostate cancer, spine stereotactic body radiation therapy, soft tissue sarcomas, skin cancer, and more. It will help you to better:

  • Recognize the importance of clinical evaluation of cancer patients during various treatment phases
  • Outline effective curative and palliative treatment goals
  • Explain the potential outcomes of combining immunotherapy and radiation therapy
  • Discuss the efficacy of stereotactic body radiation for spinal tumors
  • Evaluate and overcome challenges encountered in radiation oncology



Credits: 1 (AMA PRA Category 1)
Format: Online Streaming Video
Price: Free
Release Date: September 13, 2017
Expiration Date: March 13th, 2018
Summary:

TOPICS OF INTEREST:

  • Disease- and patient-factors influencing treatment choices at relapse
  • Mechanisms of drug resistance and clonal heterogeneity
  • Emerging agents: Immunodulatory derivatives, novel pathway targets, second-generation proteasome inhibitors, and monoclonal antibodies
  • Drawing on clinical trials of emerging therapies to benefit patients



Credits: 1.25 (AMA PRA Category 1)
Format: Online Streaming Video
Price: Free
Release Date: Dec 4, 2017
Expiration Date: Dec 4, 2019
Summary:

By the end of the session the participant will be able to:

  • Describe the role of the immune system in cancer and cancer therapy in metastatic melanoma.
  • Distinguish between the different forms of therapy presently approved for metastatic melanoma and apply them to practice, taking into account the following: treatment modalities and the recent clinical trial evidence supporting them.
  • Describe emerging (investigational) therapies for metastatic melanoma
  • Describe the challenges and barriers to care associated with treating patients with metastatic melanoma
Credits: 1 (AMA PRA Category 1)
Format: Online Publication
Price: Free
Release Date: 9/19/2017
Expiration Date: 9/19/2019
Summary:

Learning Objectives:

  • Summarize the most impactful findings presented at ASCO 2017 relating to Metastatic Melanoma and apply them to patient cases, taking into account any relevant barriers to care.
  • Additional objectives to be dictated by clinical content
Credits: 0.75 (CE)
Format: Online Streaming Video, Interactive Online, Multiple Formats
Price: Free
Release Date: Nov 17, 2017
Expiration Date: Nov 17, 2019
Summary:

By the end of the session the participant will be able to:

  • Apply screening criteria to a patient receiving AI therapy or androgen deprivation therapy
  • Describe the criteria for initiation of pharmacotherapy in a patient receiving AI therapy or androgen deprivation therapy and apply them to a patient case
  • Identify present pharmacotherapeutic treatments for management of a patient receiving AI therapy or androgen deprivation therapy, and describe their mechanisms of action and place in therapy
  • Describe the challenges associated with treating patients receiving AI or androgen deprivation therapies, focus specifically on the risks (e.g., adverse drug reactions, drug interactions, et cetera) of the agents and apply the information in optimizing patient care in a patient case




Credits: 40 (AMA PRA Category 1)
Format: Live Course, Multiple Formats
Price: $640 - $960
Expiration Date: 5/14/2020
Summary:

This inclusive review is designed to offer trainees and or clinicians in practice an update of clinical information as well as to help them prepare for their Radiation Oncology exams (initial certifications and MOC). The 4-day program includes didactic lectures with review questions, esyllabus (containing all PowerPoint® presentations), and designated Q&A sessions. Emphasis is on evidence-based medicine and board-relevant standards of care; incorporating new ideas, treatments, and imaging approaches. In addition, the course will cover the fundamentals of radiobiology and physics that are relevant to clinical practice. The written exams emphasize anatomy, epidemiology, etiological agents, natural history, pathology, tumor markers, the initial clinical evaluation, staging, routes of spread, selection of treatment modality and techniques, surgical and chemotherapy adjuvant treatments, follow-up treatment and evaluation, patterns of failure, and normal tissue effects including difficulties, all of these areas will be discussed in this course.

Topics covered: Pediatric Radiation Oncology *** Esophageal Cancer *** Gastric Cancer *** Pancreatic Cancer *** Colorectal Cancer *** Anal Cancer *** Hepatic and Cholangio Cancer *** Malignant Brain Tumors *** Benign Brain Tumors *** Metastases and Palliation *** Skin Tumors *** Hodgkin's Lymphoma and Plasmacytoma *** Non-Hodgkin's Lymphoma *** Head and Neck Anatomy *** General Principles *** Oropharyngeal *** Carcinoma in-situ and Miscellaneous*** Testis, Kidney, Ureter and Penis Cancer *** Early Stage Prostate Cancer *** Advanced Stage Prostate cancer *** Endometrial Cancer *** Sarcomas *** Vulvar and Vaginal Cancer *** Ovarian, Cervix and Fallopian Tubes Cancer *** Early Stage Breast Cancer *** Locally Advanced Breast Cancer ***Bladder Cancer *** Oral Cavity *** Larynx, Hypopharynx *** Nasopharynx *** Lung/Mediastinum *** Questions and Answers

Credits: 1 (AMA PRA Category 1)
Format: Online Streaming Video, Multiple Formats
Price: Free
Release Date: Nov 1, 2017
Expiration Date: April 20, 2018
Summary:

Includes Topics in

  • HR deficiencies and BRCA mutations
  • Recurrent ovarian cancer
  • Data on available and emerging PARP inhibitors
  • Personalizing treatment selection
  • Companion Diagnostics
Credits: 1 (AMA PRA Category 1)
Format: Online Streaming Video, Multiple Formats, Interactive Online
Price: Free
Release Date: Feb 24, 2019
Expiration Date: Feb 24, 2021
Summary:

By the end of the session the participant will be able to:



  • Apply existing guideline recommendations in the diagnosis of HCC
  • Identify present and emerging pharmacotherapeutic treatments for management of unresectable HCC and apply them to patient cases using evidence-based medicine.
  • Describe how to manage challenges that arise during treatment with present and emerging pharmacotherapeutic treatments for HCC, including adverse effect management, and apply that knowledge to a patient case
  • Describe the challenges associated with treating patients with HCC, focusing specifically on the risks (e.g., adverse drug reactions, drug interactions, et cetera) of the agents used to treat the disease, and apply that information in optimizing patient care in a patient case
Credits: 56 (AMA PRA Category 1)
Format: Audio CD, Online Video
Price: $499.00
Summary:

Practical Reviews is just that—practical, expert reviews of the most relevant articles from leading medical journals in Cancer Management.Our expert medical faculty conduct a comprehensive review of hundreds of articles from current leading medical journals so you don't have to. Our knowledge leaders summarize the most relevant medical research for you to review at your convenience and add commentary with perspective for applying these findings in your own practice.

Credits: 1.25 (AMA PRA Category 1)
Format: Online Streaming Video
Price: Free
Release Date: Dec 4, 2017
Expiration Date: Dec 4, 2019
Summary:

By the end of the session the participant will be able to:

  • Describe the role of the immune system in cancer and cancer therapy in metastatic melanoma.
  • Distinguish between the different forms of therapy presently approved for metastatic melanoma and apply them to practice, taking into account the following: treatment modalities and the recent clinical trial evidence supporting them.
  • Describe emerging (investigational) therapies for metastatic melanoma
  • Describe the challenges and barriers to care associated with treating patients with metastatic melanoma



Credits: 44 (AMA PRA Category 1)
Format: Online Streaming Video, MP3, MP4, Multiple Formats
Price: $1,795.00
Release Date: June 30, 2018
Expiration Date: June 30, 2021
Summary:

Improve Patient Care in Hematology and Oncology

The Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. Relevant topics are addressed in case-based board review presentations. Improve patient care by learning to:

  • Perform differential diagnosis of complex hematologic and oncologic disorders
  • Identify and apply current therapeutic options for hematologic and oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to hematology and oncology
  • Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
  • Illustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification Hematology and Oncology examinations
Credits: 31.5 (AMA PRA Category 1)
Format: Online Streaming Video, MP3, MP4, Multiple Formats
Price: $1,295.00
Release Date: June 30, 2018
Expiration Date: June 30, 2021
Summary:

Earn CME Credit with this Board Review in Oncology

The Brigham and Dana-Farber Board Review in Oncology is a CME course designed to update knowledge and improve management strategies. Case-based presentations from a distinguished faculty of experts will enhance patient care while you prep for the board exam by learning to:

  • Apply recommended oncology guidelines in clinical practice
  • Perform differential diagnosis of complex oncologic disorders
  • Identify and apply current therapeutic options for oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to oncology
  • Illustrate knowledge of pathophysiology as it applies to management of oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification oncology examinations
Credits: 23.75 (AMA PRA Category 1)
Format: Online Streaming Video
Price: $1,095
Release Date: July 31, 2018
Expiration Date: July 31, 2021
Summary:

Explore the Latest in Diagnosis, Management and More
Thoracic Imaging – 2018 covers a range of topics, including lung cancer screening, diffuse lung diseases, quantitative imaging, big data and deep learning, pulmonary infections, oncologic imaging and interventional management, evidence-based imaging and educational topics, cardiothoracic emergencies, and cardiovascular imaging. It will help you to better:
Recognize basic concepts in imaging interpretation including pitfalls, anatomic variants and frequently missed diagnoses
Discuss the role of imaging in the screening, diagnosis, evaluation and management of cardiac diseases, including those affecting coronary arteries and great vessels of the thorax
Describe current and emerging applications in radiography, CT, MR and PET
Apply a practical approach to the assessment and management of infectious diseases, mediastinal abnormalities and diffuse lung diseases

Share This